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Abstract: Diverse types of healthcare systems in countries offer opportunities to explore the
heterogeneous sources of health financing. This paper widely explores the effect of the business
cycle on subsidized, voluntary and out-of-pocket health spending in 34 countries with different types
of healthcare systems, by the methodology of hierarchical linear modeling (HLM). We use a panel
of annual data during the years from 2000 to 2016. It further examines the business cycle-health
financing mechanism by inquiring into the mediating effect of external conditions and innovative
health financing, based on the structural equation modeling (SEM). The empirical results reveal
that the business cycle harms subsidized spending, whereas its effect on voluntary and protective
health spending is positive. Results related to the SEM indicate that the mediating effect of external
conditions on the relationship between the business cycle and health financing is negative. However,
we find that the business cycle plays a positive effect on health financing through innovative health
financing channels. Thus, designing and implementing efforts to shift innovative health financing
have substantial effects on the sustainability of healthcare systems.
Keywords: business cycle; health financing; subsidized; voluntary and out-of-pocket health spending;
hierarchical linear model; structural equation modeling
1. Introduction
Concern about the impact of business cycle on global health financing is vital for achieving the
sustainability of healthcare systems and Universal Health Coverage (UHC). According to the 2016
report of the World Health Organization (WHO), the primary objective of health financing is to achieve
expected health outcomes or strengthen the health climate [1]. Business cycle theories have typically
resorted exogenous shocks, such as income inequality, unemployment, economic uncertainty in order
to generate such features of healthcare systems [2–7]. The existing literature has repeatedly found
evidence of public or private health financing. However, we lack a framework to systematically analyze
the impact of business cycle on global health financing.
This paper firstly evaluates the impact of the business cycle on different sources of health financing.
Building on heterogeneities among different types of healthcare systems setup, we employ a hierarchical
linear model (HLM) to snapshot the distributions of business cycle to health financing among different
healthcare systems [8–11]. The healthcare system not only enables people of a country to achieve
equity from using health services but also protects patients or households from “financial ruin” [12–14].
Equity in healthcare systems is heavily correlated to the primary goal of financial protection but
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is conceptually heterogeneous. On the one hand, the gap between the demand and actual use of
health service elevates the inequity of healthcare systems [15]. Subsidized health spending could
be regarded as a tool to get adequate access to health service and be called for strengthening the
equity [16–18]. On the other hand, financial protection is at the center of efforts to enjoy healthcare
service. Overall, financial protection should be distributed according to the financial incentive [19,20].
Voluntary health spending is a direct financial incentive for unnecessary medical treatment. Besides,
it allows households to share the risk of medical costs [21–23]. Out-of-pocket health spending can
be used to assess the extent of financial protection within a country [24]. Obviously, in the absence
of information asymmetry and externality, the business cycle exerts a comparable effect on health
financing among different types of healthcare systems. In this sense, an important question is, how the
business cycle will be distributed to health financing among different healthcare systems.
This paper specializes a structural equation model (SEM) to show that external conditions
and innovative health financing exert mediating effects towards business cycle-health financing
mechanisms. External conditions are shaped by government action, public policy, and socioeconomic
context. Theoretically, there are several factors that potentially affect health financing. On the one
hand, the supply-side factors, such as government actions, human resource management and reception
of patients, could help change the out-of-pocket health spending [19,25]. On the other hand, Sanger
et al. [26] investigated the effect of economic burden on the formal payment for healthcare. Therefore,
exploring intermediate effects of external condition could highlight the transferred channel between
the business cycle and health financing. In terms of innovative health financing, Atun et al. [27]
systematically investigated the innovative financing instruments for global health. Innovative health
financing could be regarded as a tool to track down the national financing related to health categories.
With the increasing reliance on innovative financing to sustain healthcare systems, the important
question is what should be the way forward in improving the efficiency and number of innovative
financing instruments used to augment health financing toward healthcare systems [28]. To date,
we lack a deep understanding for the mediate effect of innovative financing, and such evidence is
necessary to improve the share of innovative financing instruments in health spending. Thus, the aim
of this study is to offer evidence to explore the effect of the business cycle on global health financing
through external conditions and innovative financing channels among different countries.
To explore the patterns described by the business cycle-health financing mechanisms, this paper
investigates the heterogeneity and channels on health financing in 34 countries over a 16-year period,
2000–2016. Accordingly, the high share of out-of-pocket health spending could better reflect a lack of
financial risk protection for households, that is also continue to be a major source of health financing
in countries. Taking into account heterogeneities among different types of healthcare systems, this
paper divides sample countries into three groups by the mean value of the share of out-of-pocket
health spending from 2000–2016 to measure the types of healthcare systems. Building on a mediating
mechanisms setup, we also develop a framework based on the SEM to separately explore the channel
role of external conditions and innovative health financing on the relationships between business cycle
and health financing among different types of healthcare system within countries.
This study contributes to the healthcare system literature in some aspects. First, there is a need to
comprehensively and comparatively explore the impact of business cycle on subsidized, voluntary
and out-of-pocket health spending. Studies on global health financing comprehensively estimated
the health spending disaggregated by sources and compared the expected and potential spending in
healthcare systems [12]. Concerning the impartial and protective aspects, it is generally accepted that
the influence on global health financing should not only assess the single source of health outcomes
but also eliminate heterogeneity associated with economic status in countries. Thus, this paper widely
explores the effect of the business cycle on subsidized, voluntary and out-of-pocket health spending in
lower-middle, upper-middle, and high-income countries by the HLM. Furthermore, the present study
is different from existing literature that it separately investigates the impact of the business cycle over
global health financing through path variables. It could be regarded as an exploration for effective
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channels. These channels are used to capture the effect of the business cycle on health financing, or to
infer if increased health financing is linked to more business cycle or vice versa. What is more, different
business cycle-health spending mechanisms show a varying level of heterogeneous income countries.
The logical organization of the paper is shown in Figure 1. Section 2 presents the research
hypothesis in this study. Section 3 depicts the impact of the business cycle on health financing in
different countries. Furthermore, Section 4 analyzes the transfer channel between the business cycle
and health financing. The conclusions and policy implications are shown in Section 5.
Figure 1. The logical organization of this paper.
2. Research Hypothesis
Why have influential patterns of business cycles varied among different health financing? Figure 2
represents the logical organization of the hypothesis. In general, the business cycle affects health
financing primarily through internal and external factors, such as broader issues of efficiency and
market failure in healthcare systems, among different types of spending [29,30]. Specifically, the
business cycle exerts negative effect on subsidized health spending. On the one hand, the negative
effect related to the objective of subsidized spending. The primary aim of subsidized spending is to
ensure the equality of consumers to assess the healthcare service [31,32]. To stabilize the healthcare
system and improve its efficiency, governments or authorities began implementing ‘conversion period’
programs [33]. On the other hand, demands of health service also determine this negative effect.
Consumers also could experience the change in their health quality according to the heterogeneity
of working conditions during different phases of the business cycle [3,7,34]. The gaps existed in
accessing to healthcare service elevates the negative effect of the business cycle on subsidized health
spending [15].
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Figure 2. Hypothetical model.
The effect of the business cycle on voluntary and out-of-pocket health spending shows a different
picture. These relationships between the business cycle and voluntary and out-of-pocket spending
are determined by households’ after-tax-and-transfer income (ATTI) and health conditions. On the
one hand, as the asymmetry of information, the increase of ATTI and the resulting uncertainty in
economy may weaken the expectations of consumers and efficiency. This leads to a larger deterioration
of voluntary and out-of-pocket health spending [35]. On the other hand, countries during different
phases of the business cycle negatively influence their populations’ health conditions [36]. Less income
effectively creates financial barriers to access health services, especially in healthcare systems heavily
depend on out-of-pocket health spending [37]. Given the stability of the business cycle in countries
with different types of healthcare systems, what is more, the expectation of participants are responsible
for the negative effect of the business cycle on voluntary and out-of-pocket health spending [38].
Accordingly, this study presents the first hypothesis:
Hypothesis 1. Generally, the business cycle has a negative impact on subsidized spending, whereas the effect of
the business cycle on voluntary and out-of-pocket health spending is positive.
The question exists of how external conditions affect health financing could be grouped into two
broad categories: the national fiscal position and consumers’ demand. From the perspective of the
national fiscal position, this could include a surprise in fiscal risk or unforeseen financing constraints
of healthcare systems [39]. On the one hand, external conditions could trigger cascades of events that
heavily impact healthcare systems by changing unemployment and poverty, further resulting in the
uncertainty of health spending [40–42]. On the other hand, external conditions may be regarded as
unforeseen financing constraints of healthcare systems [43]. More specifically, external conditions exert
uncertainty on working and living conditions, which could be seen as one of the barriers to access
to healthcare service [3]. In terms of the consumers’ demand, consumers could expect to find higher
wages to satisfy the normal and unexpected expenditure of healthcare service [6]. However, external
conditions have also been related to higher prevalence of risk behaviors, such as smoking and less
healthy lifestyles [44]. All these agreements highlight the determinant role of external conditions in
health financing.
The relationships between business cycle and external conditions offer a unique opportunity
to test the mediating effect of external conditions [45]. First, the relationship between the business
cycle and the fiscal position of countries has witnessed this mediating effect. It is well-known that
one country could be regarded as an expected regional economy if it timely and more professionally
exposes the economic uncertainty in either the overall economy or the specific industry during different
phases of the business cycle. This relationship has played an important role in reducing fiscal risks and
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financing constraints in healthcare systems [46]. Second, the consumers’ demand is heavily associated
with the business cycle. A consumer’s demand for healthcare service responses to a shock could also
be conceptualized as a diversified economy [30]. In this context, it would stand to reason that the
business cycle has exposed the fundamental of economy, including fiscal position and the demand side
of healthcare service, and eventually resulting in the changes in health financing.
As mentioned above, it could be clearly noted that:
Hypothesis 2. There is a mediating effect of external conditions on the relationship between the business cycle
and health spending.
Two priorities for meeting the health R&D highlight the crucial role of innovative financing in
healthcare systems. Accordingly, two elements are recommended to explain the relationships between
innovative health financing and health financing: a guarantee of sustainable financing and resource
allocation [47]. On the one hand, innovative health financing offers a new opportunity for transferring
traditional donor funding in novel ways to improve health financing [27]. Since innovative health
financing enriches the ways that donors invest their funds, it is likely to increase in health spending. On
the other hand, innovative health financing could be regarded as a shared global public resource [43].
Indeed, inequalities associated with regional and social resource allocation leave the poor with a greater
unmet demand for healthcare services [48]. Another explanation is that innovative financing has
effectively pooled and channeled financing from innovative health financing to beneficiary countries.
For example, innovative instruments, such as exchange-traded funds failed to generate any valuable
financing [49]. The Airline Levy, however, has become a steady source of global health financing.
However, this situation is not applicable to rich countries, such as Norway, UK and USA. Consequently,
there are heterogeneous effects of innovative health financing on health financing among different
types of healthcare system.
Innovative health financing has been primarily channeled to relationships between the business
cycle and health financing. Given the heterogeneous efficiency in countries with different types of
healthcare systems, innovative financing will not be essential to stabilize the healthcare system, and it
is difficult to collect international resources [50]. For one thing, economic uncertainty related to the
business cycle will create risks for transferring traditional funds, which further lead to a major failure
in the sustainability of health financing. For another, the business cycle also changes the conversion
efficiency in healthcare systems as a result of the slowdown in the competitiveness of the economy
and the shortage of resource allocation. With the commitment to the Millennium Development Goals,
additionally, these disparities among different types of healthcare systems could intensify due to the
heterogeneity of political instability, which is testing the effectiveness of healthcare systems in different
countries [29]. In this vein, it could stand to reason that there are heterogeneous mediating effects on
innovative health financing towards the impact of the business cycle on global health financing in
countries with different types of healthcare systems.
Accordingly, this study concludes the last hypothesis:
Hypothesis 3. Innovative health financing mediates the association between the business cycle and global health
financing.
3. The Impact of the Business Cycle on Global Health Financing
3.1. Hierarchical Linear Model
A hierarchical linear model (HLM) can be employed as an effective tool to investigate the effect of
the business cycle on global health financing among subsidized, voluntary and out-of-pocket health
spending. Van and Nissen [51] developed a review of HLM in exploring the hierarchically nested
structure in education datasets. Additionally, a large number of studies investigated the nested effect
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in the fields of environmental, firm and others [52,53]. However, sparse attention has been paid to
the exploration of healthcare systems. Health financing is usually organized at a nested structure,
namely, relationships between health financing and the business cycle are properly conceived as nests
within the types of healthcare system. Actually, health financing and variables used in this paper
(this could be introduced in Section 3.2) are tracking data that means they can be used as repeated
measurements among multiple years in the countries. On the one hand, the characteristics of a country
might be nested within the type of the healthcare system. On the other hand, these diverse types
could, in turn, be nested within states. In other words, the business cycle could vary over different
types of healthcare systems which are heavily related to the relationship between business cycle and
external environment such as disease control and social stabilization. Moreover, a robust healthcare
system is built to guarantee a fair access to health services and to prevent external shocks. Thus, this
means we have to explore whether and how health financings are impacted by the interaction between
the business cycle and types of the healthcare system. Using traditional linear models may ignore
these nested characteristics which could lead to bias. Alternatively, the HLM can accomplish this by
estimating unique models for each country with a different type of healthcare system. Thus, this paper
uses the HLM. With the HLM, observation of different years forms the first level of HLM, whereas the
type of healthcare system forms the second level. The specific models are as follows.
Level 1 could be expressed as (1):
HSPt,i = pi0,i + pi1,iBCt,i + pi2,iUNFt,i + pi3,iSERt,i
+pi4,iGOVt,i + pi5,iUEMt,i + pi6,iTECt,i + pi7,iSWt,i + εt,i
(1)
Similarly, Level 2 could be shown as (2)-(3):
pi0,i = ϕ00 + ϕ01 × IH + ϕ02 × IM + τt,i (2)
pi1,i = ϕ10 + ϕ11 × IH + ϕ12 × IM (3)
Mixed Model:
HSPt,i = ϕ00 + ϕ01 × IH + ϕ02 × IM
+ϕ10 × BCt,i + ϕ11 × IH × BCt,i + ϕ12 × IM × BCt,i
+pi2,iUNFt,i + pi3,iSERt,i ++pi4,iGOVt,i + pi5,iUEMt,i + pi6,iTECt,i + pi7,iSWt,i + τt,i + εt,i
(4)
where BCt,i refers to the business cycle for country i at year t . IH and IM are dummies for countries
with the high and medium share of out-of-pocket health spending. UNFt,i and SERt,i represent the
public health conditions which are ‘Under Five Mortality Rate’ and ‘people using safely managed
sanitation services’, respectively. GOVt,i , UEMt,i and TECt,i stand external conditions within a country
which respectively are ‘government effectiveness’, ‘unemployment’ and ‘patent applications’. SWt,i
represents structural weakness which is ‘compulsory financing arrangements’. Additionally, our
interesting mainly lies in ϕ10 , ϕ10 + ϕ11 and ϕ10 + ϕ12 which respectively stand for the effect of the
business cycle on health financing among different types of the healthcare system.
3.2. Data and Variables Selected
Accordingly, we use panel annual data of 34 countries from 2000 to 2016 because of the availability
of data. We first depict the variables selected in this paper. Then, this paper presents the measurement
of the healthcare system’s type. Specifically, a brief description of all variables used in this paper is
shown in Table 1.
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Table 1. Variables selection for the hierarchical linear model (HLM).
Nature of
Variables Variables Abbr. Measurement Description Source
Dependent
variables
Government
Health
Expenditure
GHE
Domestic General
Government Health
Expenditure as %
Current Health
Expenditure
This indicator depicts that
governments give subsidy to
healthcare systems.
GHE database
private prepaid
plans VHI
Voluntary Financing
Arrangements as % of
Current Health
Expenditure
This shows the voluntary
prepayment schemes to
healthcare systems.
GHE database
Out-of-Pocket
Expenditure OPE
Out-of-pocket as % of
Current Health
Expenditure
This highlights the importance
of assessing the extent of
financial protection in
healthcare systems.
GHE database
Explanatory
variable Business Cycle BC Real GDP
This variable reflects the
economic operation within a
country.
IFS database
Control variables
Under Five
Mortality rate UNF
Mortality rate, under-5
(per 1,000 live births)
This indicator concerns about
the global monitoring of child
mortality.
WDI database
People using
safely managed
sanitation
services
SER
People using safely
managed sanitation
services (% of
population)
This indicator indicates the
percentage of people using
improved sanitation facilities
that are not shared with other
households and where excreta
are safely disposed of in
situation or transported and
treated offsite.
WDI database
Government
Effectiveness GOV
Government
Effectiveness
This indicator represents a
proxy for the quality of
government.
WGI database
Unemployment UEM Unemployment, total (%of total labor force)
This indicator is of critical
importance in measuring the
(in)ability of workers to
readily obtain gainful work
within a country.
WDI database
Patent
applications TEC
Patent applications,
residents
Patent applications are
worldwide patent applications
filed through the Patent
Cooperation Treaty procedure
or with a national patent office
for exclusive rights for an
invention-a product or process
that provides a new way of
doing something or offers a
new technical solution to a
problem.
WDI database
Compulsory
Financing
Arrangements
SW
Compulsory Financing
Arrangements as % of
Current Health
Expenditure
This reflects inadequate
financing and resource
misallocation in healthcare
systems.
GHE database 1
1 Note: 1. Abbr. means the “Abbreviation”. 2. GHE database represents the “Global Health Expenditure database”.
IFS database means the “IMF (International Monetary Fund) International Financial Statistics database”. WDI
database is the “World Development Indicators database”. WGI database represents the “World Governance
Indicators database”.
The dependent variables include subsidized, voluntary and out-of-pocket health spending. From
the perspective of subsidized health spending, government health expenditure could be regarded
as an effective tool to reduce the gaps between the individuals’ need and their ability to use the
health service. In terms of voluntary health spending, voluntary financing arrangements depicts
voluntary prepaid schemes to healthcare systems. Additionally, out-of-pocket expenditure indicates
the individual’s ability-to-pay and refers to financial protection in a country. Specifically, the higher
the share of out-of-pocket expenditure in total health expenditure, the more limited the financial
protection in a country. In this sense, this paper selects government health expenditure of total
general government expenditure, voluntary financing arrangements of current health expenditure
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and out-of-pocket expenditure of total expenditure obtained from Global Health Expenditure (GHE)
database to measure the subsidized, voluntary and out-of-pocket health spending, respectively.
The main explanatory variable is the business cycle. Commonly, the gross domestic product
is regarded as a measurement of business cycle, which can be obtained from IMF’s (International
Monetary Fund) international financial statistic (IFS) database. Real GDP measurements are retrieved
at constant prices and are used to calculate economic growth by removing the effect from general price
levels within countries. Moreover, the Hodrick-Prescott filter (HP-filter) is a non-parametric method
which is commonly used to filter trend and cycle components. To get a sense of the marginal effect of
the business cycle on health financing, this paper employs HP-filtered real Gross Domestic Product
(GDP) to compute the aggregate business cycle. Specifically, the business cycle was detrended from
annual data using the HP-filter with a smoothing parameter of 100, which could be regarded as an
effective parameter to snapshot the characteristics of GDP.
The incidence of health spending relates to different health conditions and socioeconomy. Arguably,
the crucial factors of health financing are public health conditions, economic conditions and structural
weakness [5,20,43]. In terms of public health, this paper uses the Under Five Mortality Rate (UNF)
and People using safely managed sanitation services (SER) obtained from world development index
(WDI) database, since they could capture perceptions of the health of people. At a specific level, the
UNF concerns about the global monitoring of child mortality, and the SER depicts the percentage of
people using improved sanitation facilities that are not shared with other households. As a proxy for
the external conditions, this paper selects Government Effectiveness (GOV), Unemployment (UEM)
and Patent Applications (TEC). The UEM, collected in the WDI database, is not only a signal of
economic distress but plays a key role in increasing health financing in healthcare systems. The TEC,
which is also obtained from WDI database, offers a new technical solution to healthcare systems.
Moreover, government could mitigate the information asymmetry in the health sector, for instance,
between patients and doctors. Government effectiveness (GE) compiled by the world government
index (WGI) database in world bank captures perceptions of the quality of public services [20]. As a
proxy of structural weakness, compulsory financing arrangements (SW) reflects inadequate financing
and resource misallocation in healthcare systems. Thus, this paper employs compulsory financing
arrangements to express structural weakness.
The rank of OPE could be employed to amplify the type of healthcare system in countries. It is
widely accepted that health financing is heavily associated with the effectiveness of healthcare systems.
Indeed, the high share of OPE means higher financial risk protection for households, this is also crucial
for assessing the effectiveness of the healthcare system in countries [26]. If the OPE is a high percentage
of total health expenditure, this would generally suggest limited financial protection, as a result of
a lower effectiveness of healthcare system. Consequently, households with a higher share of OPE
could contribute a higher share of their income in accessing healthcare services. Therefore, the share of
OPE could be regarded as an effective tool to measure the type of healthcare system within countries.
For analysis, out-of-pocket health spending has been grouped to form an inter-sectional variable.
Specifically, this paper firstly computes the average value (AV) of OPE in countries over the sample
period. Secondly, we sort these AV from 1 to 34 in descending order (These results are available upon
request). Of those average value of OPE and the balance between different samples, this paper regards
Rank 1–11 as a high-type system (H), Rank 12–22 as a middle-type system (M) and others as a low-type
system (L). The details are shown in Table 2, with countries listed in groups and their abbreviation.
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Table 2. The results of the sample divided.
Categories Rank Abbr. Country Lists
High OPE 1–11 H Armenia, Azerbaijan, Bangladesh, Ecuador, Egypt,Georgia, Guatemala, Morocco, Iran, Pakistan, Philippines
Middle OPE 12–22 M Bosnia and Herzegovina, China, Korea, Malaysia, Mexico,Paraguay, Peru, Singapore, Tunisia, Uzbekistan, Venezuela
Low OPE 23–34 L
Algeria, Belarus, Brazil, Jordan, Kazakhstan, Mongolia,
New Zealand, Norway, Russian Federation, Saudi Arabia,
United Kingdom, United States 2
2 Note: Abbr. means the “Abbreviation”.
3.3. The Business Cycle Effects on Global Health Financing
The quantitative investigation results are reported in Table 3 and Figure 3. Specifically, Table 3
displays the estimation of parameters in equation (4). Figure 3 snapshots the ϕ10 , ϕ10 + ϕ11 and
ϕ10 + ϕ12 among the GHE, VHI, and OPE.
Figure 3. The effect of the business cycle on different types of health financing.
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Table 3. The estimation of equation (4).
HSP Parameters Coef. St. D t-Value Prob.
GHE
ϕ00 0.661 0.029 23.14 0.000
ϕ01 −0.362 0.041 −8.766 0.000
ϕ02 −0.169 0.041 −4.116 0.000
ϕ10 −0.003 0.017 −0.149 0.882
ϕ11 −0.003 0.212 −0.159 0.874
ϕ12 −0.002 0.024 −0.093 0.927
C.V. YES
Sum.
H −0.006
M −0.005
L −0.003
VHI
ϕ00 0.333 0.028 12.070 0.000
ϕ01 0.351 0.039 8.811 0.000
ϕ02 0.175 0.039 4.391 0.000
ϕ10 0.031 0.020 1.504 0.133
ϕ11 −0.055 0.024 −2.246 0.025
ϕ12 −0.022 0.027 −0.804 0.422
C.V YES
Sum.
H −0.024
M 0.009
L 0.031
OPE
ϕ00 0.237 0.023 10.353 0.000
ϕ01 0.388 0.033 11.716 0.000
ϕ02 0.182 0.033 5.500 0.000
ϕ10 0.001 0.077 0.016 0.987
ϕ11 −0.020 0.094 −0.211 0.833
ϕ12 0.003 0.105 0.028 0.978
C.V. YES
Sum.
H −0.019
M 0.004
L 0.001 3
3 Note: 1. Coef. stands for the coefficient. St. D represents the “Standard error”. Prob. is the probability of
estimation and sum. means the summary of the effects of the business cycle among countries with different types
of healthcare system. 2. C.V. presents the “Control variables” and YES stands model estimation includes control
variables. The backward elimination is employed to select control variables because of their significance among
different health financing. In this vein, control variables include UNF, GOV, TEC, and SW when HSP is GHE. When
VHI is regarded as the HSP, control variables are UNF, SER, GOV, UEM, TEC, and SW. However, control variables
are SER, GOV, and SW in the OPE. The full results of equation (4) are shown in Table A1.
A comparison study of information in Table 3 reveals heterogeneous effects of the business cycle
on global health financing among subsidized, voluntary and out-of-pocket health spending. More
specifically, it is particularly interesting to note that there are negative effects of the business cycle
on subsidized health spending. On the one hand, the inverse effect of the business cycle may be
due to diseases control and social stabilization. Indeed, the downward pressure of economy in a
country becomes more precarious, and the investments are uncertain as a result of the expansion
of economic burden [41]. Consequently, the negative effect could increase the cost of diseases and
weaken disease control, which further intensify the inequality in healthcare systems. According to
the primary aim of subsidized health spending, governments or authorities began increasing the
expenditure for households to access health services. Additionally, healthcare systems play crucial
roles in social stabilization since their roles in basic demand for households. People may be more
fearful about increasing their economic burden since the levels of living and working have been
substantially weakened. It is estimated that healthcare systems could effectively improve happiness
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even though there are limitations to investment. On the other hand, the negative effects are also related
to the quality of health. For instance, business cycles are often negatively accompanied by the spread
of communicable diseases, which offer challenges to the stabilization of healthcare systems. Therefore,
the business cycle has a negative effect on subsidized health spending.
As expected, the effect of the business cycle on voluntary and out-of-pocket health spending is
positive. From the perspective of voluntary health spending, the fact that the positive effect of the
business cycle can be fully attributed to the households’ willingness to prepay for healthcare services.
For instance, proper working conditions expand the ATTI since the ATTI offers a chance to depict cash
and non-cash safety. Further, the ATTI promotes the households’ willingness and consequent ascension
of voluntary health spending. In terms of out-of-pocket health spending, the high dependence between
economic burden and participants’ income and health conditions as a major mechanism is along
expected lines. There are strong reasons to believe the economic burden effectively leads households
to scale back an “affluent” lifestyle, since they reduce their expenditure on eating outside the home,
and they choose to walk instead of driving. What is more, with the downward pressure of the business
cycle, households rely more on private expenditure and even sell their assets to access healthcare
services. As a result, they are more dependent on out-of-pocket health spending. These results indicate
the recent evidence of the positive relationship between the business cycle and private health spending.
However, the picture changes a little in countries with a high-type healthcare system (H). As
shown in Table 3, it is clear to note that the business cycle in these countries shows a negative effect
on subsidized, voluntary and out-of-pocket health spending. These unreasonable results may reveal
the role of fluctuations in the business cycle and participants’ expectations. Economic parameters
such as the GDP (current US$; unit/trillion) and its volatility behave quite different in countries with
diverse types of systems. Commonly, it is worth to note that the volatility of the business cycle during
sample periods of High-type is higher than that in countries with a Middle- and Low-type system,
which is 0.033, 0.027 and 0.028 (Source: author estimation). The intense fluctuation in countries with
high-type healthcare system may weaken expectations of the household. Consequently, households
spend less disposable income in the “affluent” lifestyle as a result of the deterioration of voluntary
and out-of-pocket health spending. Furthermore, this paper examines to what extent the effects of the
business cycle on subsidized, voluntary and out-of-pocket differ across different types of healthcare
systems. The results are shown in Figure 3.
The business cycle effects on global health financing are closely related to the healthcare systems
within the countries. As shown in Figure 3, it is worth to note that the impact of the business cycle
in high-type countries is generally higher than that in low-type countries. This is no surprise but
due to the heterogeneous effectiveness of healthcare systems. The effectiveness is heavily related to
equality to access healthcare services. Indeed, high-type healthcare systems are financed through some
crucial resources such as social health insurance, private health insurance, taxation and out-of-pocket
payments. However, effective programs of the healthcare system require stable financing which
guarantees a balance between the burden of paying according to the ATTI and benefits from health
spending according to demand. Additionally, the lower effectiveness in countries with high-type
systems is, the higher the financial barriers to access health services. In this vein, the business cycle
in these countries more sensitively affects health financing as the limited source and less effective of
healthcare systems.
4. The Mediating Effects on Business Cycle-Health Financing Mechanisms
This section describes empirical regularities regarding the mediating effect of external conditions
and innovative financing on business-cycle-health-financing mechanism based on structural equation
modeling (SEM). We first briefly develop a research design that will guide our empirical analysis to
follow the procedure of SEM. Later, we introduce the mediating effect of external conditions on the
business-cycle-health-financing mechanism. Finally, we also discuss the effect of business cycle on
health financing through the innovative financing channel.
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4.1. Research Design
4.1.1. Methods Selected
The structural equation modeling (SEM) in this study successfully depicts the relationship among
business cycle (BCycle), external conditions (ECondition), innovative health financing (IFinancing) and
health financing (HFinancing) based on AMOS.24. Xiong et al. [54] offer a comprehensive review of
SEM applications from perspectives of SEM design, SEM development and beneficial issues for further
research based on the SEM. Since the seminal study by Bentlers [55], who models the attitude-behavior
relations in psychological science based on SEM, the SEM has been employed to analyze safety
behaviors, project management and urban environments, and it becomes a quasi-routine technology
in the social science [56]. However, studies that measure the mediating effect of the ECondition and
IFinancing using the SEM are scarce. What is more, the possibility of modeling the dependencies and
testing the ambiguous form of BCycle, ECondition, IFinancing and HFinancing could be regarded as
the main reason for using the SEM. On the one hand, it is difficult to construct the form of BCycle,
ECondition, IFinancing and HFinancing since a single variable cannot comprehensively represent
their abstract characters. On the other hand, to achieve accurate research, we also need to assess the
causal relationship between BCycle, ECondition, IFinancing and HFinancing. Indeed, the SEM could
be considered as a unique technology that simultaneously estimates the factor analysis and the path
analysis. Compared with traditional techniques such as multivariate regression, in other words, the
SEM can simultaneously explore the assessment of BCycle, ECondition, IFinancing and HFinancing as
well as relationships among them [57]. Next, we briefly introduce the methodological procedure in
this paper.
4.1.2. Model Conceptualization
Model conceptualization, according to Table 4, focuses on constructing the measured model
between BCycle, ECondition, IFinancing, HFinancing and observed variables. Specifically, observed
variables are selected from theoretical reviews for background variables. For the observed variables of
BCycle, large investigations indicate that real GDP, real GDP growth, nominal GDP and nominal GDP
growth impact the business cycle [4,35]. As noted in Section 3.1, the real and nominal GDP respectively
depicts economic conditions with(out) the impact of general price levels. Additionally, GDP and GDP
growth are used to calculate the flux shape and its changes. All GDP measurements were detrended
using HP-filter with a smooth parameter of 100, which could be regarded as an effective parameter to
snapshot the characteristics of GDP.
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Table 4. Variables selection for structural equation modeling (SEM).
Latent Variables Observed Variables Abbr. Source
Business cycle (BCycle)
• Real GDP BC1 IFS database
• Real GDP growth BC2 IFS database
• Nominal GDP BC3 IFS database
• Nominal GDP growth BC4 IFS database
External conditions
(ECondition)
• Under five mortality rate EC1 WDI database
• People using safely managed sanitation services EC2 WDI database
• Unemployment EC3 WDI database
• Compulsory Financing Arrangements of
Current Health Expenditure EC4
GHE
database
Innovative financing
(IFinancing)
• Number of patents IF1 WDI database
• GERD Medical and health science IF2 UNESCOdatabase
Health financing
(HFinancing)
• General government expenditure on health of
total general government expenditure HF1
GHE
database
• Private prepaid plans of total expenditure
on health HF2
GHE
database
• Out-of-pocket expenditure of total expenditure
on health HF3
GHE
database
In terms of ECondition, existing literature considered several main streams of potential factors,
including public health conditions and economic fundamentals. It is widely accepted that Under Five
Mortality and people using safely managed sanitation services contribute to public health conditions
within a country and further reflect the external conditions. Other factors such as unemployment
and compulsory financing arrangements of current health expenditures could be regarded as some of
the external conditions. For the observed variables of IFinancing, this paper selected them based on
the need to balance between inputs and outputs. Besides the patent selected in Section 3.1, we also
employed gross domestic expenditure on R&D (GERD) for medical and health science (IF2) obtained
from United Nations Educational, Scientific and Cultural Organization (UNESCO) database to capture
the innovative input for healthcare systems. The IF2 provides additional funding for healthcare
systems and also indicates the potential to expand fiscal space. Above all, GERD medical and health
science is found as the input, and the number of patents is the output. They further indicate the
source of IFinancing. From the perspective of HFinancing, subsidized, voluntary and out-of-pocket
health spending is crucial financing into healthcare system planning. Thus, this paper selected general
government expenditure on health of total general government expenditure, private prepaid plans
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of total expenditure on health and out-of-pocket expenditure of total expenditure on health as good
measures of HFinancing.
4.1.3. Path Diagram Construction
According to the hypothesis, this paper constructed an initial structural model as shown in
Figure 4. As we all know, the variables in circles were defined as latent variables. The ECondition and
IFinancing are deemed as crucial paths for effectively understanding, foreseeing and achieving the
goal of UHC under the control of health financing as previously mentioned in Hypotheses 2 and 3. As
shown in Figure 4, “ECondition”, “IFinancing” and “HFinancing” can be thought of as endogenous
variables, whereas “BCycle” is an exogenous variable.
Figure 4. The initial structural model for global health financing.
4.1.4. Model Specification and Identification
Model specification mainly focused on the goodness-of-fit measured by χ2 for specific SEMs.
Therefore, we first estimated the SEM with all variables. Then, at least, we selected the most important
observed variable in the measured model through factor analysis, which is output in SEM. We
reconstructed a new SEM (Model 1) with these variables. This paper finally added variables into Model
1 and further compared χ2 with different SEMs. In this vein, this study could further identify the final
structural model. Considering the number of observations, we separately estimated the mediating
effect of external conditions and innovative financing.
4.1.5. Parameter Estimation
Commonly, AMOS offers five methods of estimating discrepancy including Maximum Likelihood
(ML), Generalized Least Squares (GLS), Unweighted Least Squares (ULS), Scale-free Least Squares
(SFLS) and Asymptotically Distribution-Free (ADF). This paper employed the ML to estimate the final
structural models and set bootstrap equal to 1000.
4.1.6. Assessment of Model Fit
Table 5 represents the recommended fitness and thus considered feasibility of the analysis. In
this paper, SEM models were separately estimated for the three types of countries. As displayed,
the final model on the path analysis for health financing is appropriately supported. Specifically,
the χ2, giving the value of 2.781, 5.643, 2.702, 0.911, 3.835 and 0.842 for each model, respectively,
indicated acceptable fit to data. Of other parameters for goodness-of-fit, the RMSEA were below the
recommended cut-off level of 0.1. Additionally, comparative fit index (CFI) for each model’s values
above 0.9 offered sufficient evidence that the fit between factor analysis and data was also acceptable.
In this context, this paper reports the mediating effects of external conditions in Section 4.2. The
mediating effects of innovative health financing are presented in Section 4.3.
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Table 5. Assessment of model fit.
Model χ2 Prob.
RMSEA
(0 to 0.1) ECVI NCP
PGFI
(>0.5)
CFI
(>0.9)
H1 2.781 0.993 0.000 0.198[0.242, 0.242]
0.000
[0, 0.000] 0.391 1.000
H2 5.643 0.896 0.000 0.213[0.242, 0.255]
0.000
[0, 2.405] 0.390 1.000
M1 2.702 0.994 0.000 0.197[0.242, 0.242]
0.000
[0, 0.000] 0.391 1.000
M2 0.911 1.000 0.026 0.188[0.242, 0.242]
0.000
[0, 0.000] 0.392 1.000
L1 0.795 0.992 0.000 0.167[0.177, 0.177]
0.000
[0, 0.000] 0.284 1.000
L2 0.842 0.991 0.000 0.152[0.177, 0.177]
0.000
[0, 0.000] 0.285 1.000
5
5 Note: 1. Model H1 stands for the exploration of mediating effects of external conditions in countries with high-type
systems, and H2 represents the mediating effect of innovative health financing. Similarly, Model M1 and M2
separately depict the mediating role of external conditions and innovative health financing towards the relationship
between business cycle and health financing in medium-type countries. Model L1 explores the effect of business
cycle on health financing through external conditions channel in low-type countries, whereas Model L2 stands for the
mediating effect of innovative health financing. 2. Prob. means the “Probability of χ2 ”. RMSEA is the “root mean
square error of approximation”. ECVI means the “expected cross-validation index”. NCP is the “non-centrality
parameter”. PGFI stands for the “parsimonious goodness of fit index”, and CFI represents the “comparative fit
index”. 3. The recommended levels of statistics are shown in parentheses, and the confidence level is shown in
square brackets.
4.2. The Mediating Effect of External Conditions
Figures 5–7 depicts the mediating effect of external conditions in countries with high, middle
and low type of the healthcare system, respectively. As seen, there were negative effects of external
conditions on the relationships between the business cycles and health financing. Specifically, the
results suggest that the business cycle had a strong negative effect on external conditions and as a result
the increase of health financing. Besides this effect, it is evident that the business-cycle-health-financing
mechanism in high-type countries depicted a different picture. Above all, the analysis elucidates that
the business cycle hurt health financing through external condition channels. This finding is in line with
the hypothesis. Therefore, the mediating effect of economic conditions makes it a noteworthy variable.
Figure 5. The mediating effect of external conditions in countries with high-type systems.
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Figure 6. The mediating effect of external conditions in countries with middle-type systems.
Figure 7. The mediating effect of external conditions in countries with the low-type system.
The results derived from the analysis clarify our theoretical hypothesis on the business-cycle-health-
financing mechanism. It was found that the mediating effect of external conditions differed according to
the type of healthcare system. Due to this mediating effect, it became obvious that external conditions need
to be considered while adjusting the strategy of healthcare systems. External conditions are considered an
important mediating factor because of two reasons: their correlation with the fiscal position of countries
and the household’s demand. In terms of the fiscal position, it includes fiscal risks and financing constraints.
As we all know, it could be found as expected external conditions if one country timely and professionally
exposes the economic uncertainty not only in the overall economy but also in specific industry [46].
Additionally, economic diversity has displayed greater fiscal positions [6]. These relationships may reduce
the fiscal risks and financing constraints, and as a consequence raise the fiscal position of countries.
Thus, the business cycle plays a negative role in external conditions. However, these events could also
affect the balance by altering the demand for health and healthcare service because of the stability of
economic parameters according to the measurement model. Specifically, it is obviously noting that external
conditions could be measured by UNF, SER and UEM. The lower values of these parameters snapshot a
more stable investment environment. As a consequence, global health financing has substantially changed.
From the perspective of the household’s demand, it is well understood that the business cycle exposed
their willingness and changed their expectations, and eventually resulted in changes in health financing.
Specifically, the main consequence of the business cycle is that it dramatically changes employment as
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the changes in competition for jobs [5]. This relationship expands the willingness and expectation for
households to contribute the investment in other areas. Accordingly, all these agreements highlight the
importance of the mediating effect of external conditions.
Moreover, the unreasonable pictures in high-type countries reveal that the mediating effect is
heavily related to fluctuations in the business cycle and participants’ expectations. As mentioned in
3.2, the business cycle in countries with high-type systems has experienced more drastic volatility
from 2000 to 2016 because of the ever-increasing role of sustainable development all over the world
compared with other groups. This volatility may be regarded as an important source, affecting the
uncertainty of external conditions and households’ expectations. Consequently, the business cycle in
high-type countries plays a negative effect on external conditions. Furthermore, this effect could trigger
the uncertainty of health spending since households could expect to find higher wages to satisfy the
normal and unexpected expenditure for healthcare service when facing an uncertain environment.
What is more, the intense volatility may also weaken expectations of households. Consequently, even
economic parameters are better, households spend less disposable income in the “affluent” lifestyle
or investment.
4.3. The Mediating Effect of Innovative Health Financing
Some interesting results, associated with the mediating effect of IFinancing, are shown in
Figures 8–10. As seen, IFinancing may positively mediate the effect of the business cycle on health
financing. Specifically, the results reveal that innovative financing is a required mediating variable
between the business cycle and health financing. Besides, it is worth to note that the mediating effect
could be associated with types of the healthcare system. In opposition to external conditions, the
analysis elucidates that the business cycle positively affects global health financing through innovative
health financing channels. Although innovative health financing does not behave to be mediating in
affecting health financing in middle-type countries, its correlation, as well as the heterogeneous effect
on health financing, makes it a noteworthy variable.
Figure 8. The mediating effect of innovative health financing in countries with high-type systems.
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Figure 9. The mediating effect of innovative health financing in countries with middle-type systems.
Figure 10. The mediating effect of innovative health financing in countries with low-type systems.
The findings derived from the analysis are in line with our hypothesis. We observed that
IFinancing had a positive mediating effect on the correlation between BCycle and HFinancing. We
see that effective control of innovative health financing would ultimately handle better financing
for the healthcare system in high- and low-countries. That innovative health financing was found
to be of positive effect reveals the crucial role of guarantee of sustainable financing and resource
allocation. Indeed, the business cycle offered the uncertainty/opportunity of economic equality which
would create effectiveness for transferring traditional funds, further resulting in a major debate on the
sustainability of financing. Consequently, this relationship changes global health financing, since the
effectiveness of transferring could attract more innovative health financing. For another, the business
cycle also showed its effect on health financing and assisting in resource allocation. The business
cycle also changed the conversion efficiency in healthcare systems as a result of the slowdown in
the competitiveness of the economy and the consequent change in share of resource allocation. As a
result, this change may create uncertainty in accessing healthcare services. What is more, inequalities
associated with regional and social resource allocation left the poor with a greater unmet demand for
healthcare services. Accordingly, all these agreements highlight the positive effect of the business cycle
on health financing through innovative health financing channels.
Moreover, the diverse results in countries with different types of healthcare systems reveal that
the mediating effect heavily is related to sharing equally, political environment and the effectiveness of
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innovative protection. On the one hand, although there are positive mediating effects of innovative
health financing on the relationship between the business cycle and global health financing, these gains
have not been shared equally because of the diverse access for healthcare service [50]. In this sense,
health financing is not affected by innovative health financing in middle-type countries as shown
in Figure 9. The BCycle increases the IFinancing, while the IFinancing does not affect HFinancing.
On the other hand, political stability such as the trajectory of flat financing may continue and will
increase the reliance on domestic and innovative financing sources to sustain and scale health programs
in low-type countries. Furthermore, this uncertainty could change sustainable financing. What is
more, these also require that innovative financing has effectively pooled and channeled financing from
innovative health financing to beneficiary countries. For instance, innovative instruments, such as
exchange-traded funds failed to generate any valuable financing. Airline Levy, however, has become
a steady source of global health financing [49]. Since the innovative financing appears to positively
mediate the business-cycle-health-financing mechanism, therefore, managers should improve the
effectiveness between the R&D expenditures and the actual use in healthcare services.
5. Conclusions
The anticipation of global health financing with regards to the business cycle is vital for promoting
UHC. The empirical results with a hierarchical linear model and structural equation modeling all point
to the heterogeneous effect of the business cycle on health financing from 2000 to 2016, disaggregated
by the source of financing. In this paper, we first explore the effect of the business cycle on global health
financing among subsidized, voluntary and out-of-pocket health spending based on a hierarchical
linear model. Furthermore, this paper investigates the mediating effect of external conditions and
innovative health financing with a framework of structural equation modeling. Specific conclusions
are as follows.
The business cycle effects in healthcare systems have stronger differences among sources of health
financing. In general, the business cycle has a negative impact on subsidized spending, whereas the
effect of the business cycle on voluntary and out-of-pocket health spending is positive. According to
the differences in the fluctuations in the business cycle and participants’ expectations among different
countries, we found that business-cycle-health-financing mechanism in countries with high-type
healthcare system is fundamentally different from that in other countries. This result is further
supported by the fact cyclical fluctuation is now a common event rather than rare occurrence. For
one thing, health financing could be regarded as a tool to determine how pressures on healthcare
system are weathered without loss of equity, quality and protection. Moreover, out-of-pocket health
spending is not acceptable on sustainable healthcare grounds. For another, this conclusion indicates
competitiveness gains which include the changes of subsidized health spending are effective ways for
the economy to adjust during different phases of the business cycle.
The external conditions negatively mediate the relationship between the business cycle and health
financing in general. Relative changes in external conditions with health financing can reflect its
mediating effect in the mechanism. However, we also find that an external condition also exerts its
positive mediating effect on business cycle-health financing mechanisms. These results further indicate
the important role of expectations of households. A better organization of external conditions from
official channels, reinforcing the informative share between household within healthcare services,
could help regulate their expectation, thus, improve the equity to access healthcare system.
The business cycle effects have been of a beneficial shock on global health financing through
the innovative health financing channel, but it is heterogeneous in countries with different types of
healthcare systems. At a more specific level, we conclude that the mediating effect of innovative
health financing will be mitigated when in middle-type countries. Additionally, innovative health
financing shows a positive effect on the business cycle, as well as health financing in countries with
both high- and low-type of healthcare systems. As innovative financings, both patents and R&D
expenditure in medical service, increase, and public health services are pushed to higher, it is evident
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that healthcare systems through innovative financing can be more responsive to economic conditions
and more effective in health spending consolidation.
These findings have implications to households and policymakers in healthcare systems. For
households, the primary aim is to reduce their private spending in healthcare systems. They have a
better focus on the health policy and are familiar with the market and economic conditions because of
the asymmetry of information. In terms of policymakers, particularly in middle-income countries, they
need to increase their effort to shift innovative health financing towards actual use if the goal of UHC is
to be realized. Additionally, the fluctuations in the business cycle and participants’ expectations play a
deterministic role on the mediating effect. Thus, policymakers also need to build equality to access the
healthcare service and guide a reasonable expectation, such as setting up a special R&D expenditure,
strengthening the supervision of innovative findings and their industrialization and improving the
sustainable development of healthcare service.
This study bears several limitations. Despite these results presented in the HLM and SEM analysis,
this paper neglects the heterogeneous effect of the business cycle during different phases, as well as the
diverse fundamental of economy and complex expectations of market participants during economic
recessions or expansion [58]. Thus, we could further explore this effect by dividing the sample periods
into economic recessions and expansions. Moreover, further studies about the moderating effect of
external conditions, innovative health financing and other factors among different income countries
would be a valuable area to investigate. What is more, a new analysis of relationships between business
or credit cycle and financing schemes could be regarded as a valuable area.
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Appendix A. Full Results of the HLM
Table A1. Full results of model (4).
HSP Parameters Coef. St. D Statistic-Value Prob.
GHE
ϕ00 0.661 0.029 23.14 0.000
ϕ01 −0.362 0.041 −8.766 0.000
ϕ02 −0.169 0.041 −4.116 0.000
τt,i 0.098 0.009 101,101.5 0.000
ϕ10 −0.003 0.017 −0.149 0.882
ϕ11 −0.003 0.212 −0.159 0.874
ϕ12 −0.002 0.024 −0.093 0.927
pi2,i 0.017 0.004 4.104 0.000
pi4,i 0.005 0.001 2.886 0.005
pi6,i 0.001 0.000 2.333 0.020
pi7,i 0.988 0.005 186.2 0.000
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Table A1. Cont.
HSP Parameters Coef. St. D Statistic-Value Prob.
VHI
ϕ00 0.333 0.028 12.070 0.000
ϕ01 0.351 0.039 8.811 0.000
ϕ02 0.175 0.039 4.391 0.000
pit,i 0.095 0.009 71,782.03 0.000
ϕ10 0.031 0.020 1.504 0.133
ϕ11 −0.055 0.024 −2.246 0.025
ϕ12 −0.022 0.027 −0.804 0.422
pi2,i −0.034 0.005 −6.162 0.000
pi3,i 0.021 0.007 3.042 0.003
pi4,i −0.004 0.002 −2.036 0.042
pi5,i −0.001 0.001 −1.850 0.064
pi6,i 0.066 0.019 3.489 0.001
pi7,i −1.021 0.006 −165.1 0.000
OPE
ϕ00 0.237 0.023 10.353 0.000
ϕ01 0.388 0.033 11.716 0.000
ϕ02 0.182 0.033 5.500 0.000
pit,i 0.079 0.006 3306.75 0.000
ϕ10 0.001 0.077 0.016 0.987
ϕ11 −0.020 0.094 −0.211 0.833
ϕ12 0.003 0.105 0.028 0.978
pi3,i 0.049 0.023 2.119 0.034
pi4,i −0.020 0.007 −2.597 0.010
pi7,i −0.744 0.024 −31.481 0.000
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